X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11072) 11072
Publication (743) 743
Book Review (167) 167
Book / eBook (54) 54
Newspaper Article (22) 22
Magazine Article (20) 20
Book Chapter (15) 15
Newsletter (11) 11
Conference Proceeding (6) 6
Dissertation (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9584) 9584
female (5346) 5346
male (4624) 4624
index medicus (3878) 3878
thrombosis (3719) 3719
middle aged (3270) 3270
thrombosis - chemically induced (2762) 2762
aged (2669) 2669
adult (2653) 2653
hemorrhage - chemically induced (2615) 2615
anticoagulants - adverse effects (2400) 2400
hematology (2256) 2256
risk factors (2214) 2214
animals (2196) 2196
peripheral vascular disease (1728) 1728
heparin - adverse effects (1718) 1718
anticoagulants - therapeutic use (1608) 1608
thrombocytopenia - chemically induced (1550) 1550
treatment outcome (1493) 1493
thrombosis - prevention & control (1266) 1266
anticoagulants (1103) 1103
thromboembolism (1069) 1069
time factors (1057) 1057
cardiac & cardiovascular systems (1052) 1052
risk (1050) 1050
anticoagulants - administration & dosage (1033) 1033
medicine, general & internal (996) 996
venous thromboembolism (987) 987
heparin (935) 935
thrombosis - drug therapy (901) 901
aged, 80 and over (863) 863
thrombosis - etiology (845) 845
surgery (832) 832
venous thrombosis - chemically induced (819) 819
therapy (800) 800
deep-vein thrombosis (776) 776
heparin - therapeutic use (742) 742
risk assessment (738) 738
venous thrombosis (736) 736
retrospective studies (735) 735
adolescent (723) 723
molecular-weight heparin (720) 720
prevention (720) 720
platelet aggregation inhibitors - adverse effects (694) 694
rats (694) 694
pharmacology & pharmacy (676) 676
contraceptives, oral - adverse effects (627) 627
mice (624) 624
abridged index medicus (611) 611
venous thrombosis - drug therapy (609) 609
blood coagulation - drug effects (602) 602
warfarin (596) 596
platelet aggregation inhibitors - therapeutic use (575) 575
disease models, animal (570) 570
blood clot (564) 564
dose-response relationship, drug (561) 561
fibrinolytic agents - therapeutic use (558) 558
prospective studies (557) 557
drug therapy (555) 555
fibrinolytic agents - adverse effects (552) 552
administration, oral (538) 538
care and treatment (521) 521
analysis (519) 519
heparin-induced thrombocytopenia (497) 497
warfarin - adverse effects (489) 489
anticoagulation (485) 485
drug administration schedule (482) 482
incidence (479) 479
thrombocytopenia (478) 478
thrombosis - blood (476) 476
recurrence (470) 470
venous thrombosis - prevention & control (470) 470
drug therapy, combination (466) 466
heparin, low-molecular-weight - adverse effects (466) 466
stroke (458) 458
aspirin (455) 455
management (441) 441
unfractionated heparin (439) 439
heparin, low-molecular-weight - therapeutic use (434) 434
heparin - administration & dosage (433) 433
bleeding (431) 431
oncology (430) 430
hemorrhage (425) 425
platelet aggregation - drug effects (420) 420
mortality (417) 417
follow-up studies (416) 416
warfarin - therapeutic use (415) 415
complications (412) 412
pulmonary-embolism (411) 411
medicine & public health (406) 406
randomized controlled trials as topic (406) 406
health aspects (402) 402
thromboembolism - chemically induced (400) 400
cancer (399) 399
pregnancy (398) 398
pulmonary embolism (398) 398
platelet aggregation inhibitors - administration & dosage (387) 387
research (386) 386
coagulation (384) 384
thrombosis - pathology (384) 384
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (49) 49
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - General (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10008) 10008
German (348) 348
French (309) 309
Spanish (109) 109
Russian (74) 74
Japanese (64) 64
Swedish (36) 36
Danish (34) 34
Italian (33) 33
Polish (30) 30
Norwegian (27) 27
Chinese (22) 22
Dutch (21) 21
Hungarian (18) 18
Czech (14) 14
Finnish (10) 10
Bulgarian (6) 6
Hebrew (6) 6
Romanian (6) 6
Portuguese (5) 5
Slovak (3) 3
Turkish (3) 3
Lithuanian (2) 2
Croatian (1) 1
Korean (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2011, Volume 103, Issue 17, pp. 1299 - 1309
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 9 - 19
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 12, pp. 1131 - 1141
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 2, pp. 136 - 148
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 6, pp. 511 - 520
Journal Article